GlassScriptPhysician profile
Chih-Hong Young
NPI 1417919572
$401.93
in general payments reported to CMS, 2019-2025
8 companies · $18.43 in 2025
The $18.43 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $126 · 2022: $70.71 · 2023: $25.11 · 2025: $18.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $111.97 | 2019 | |
| Glaxosmithkline, LLC. | $100.98 | 2021-2023 | Nucala |
| Janssen Pharmaceuticals, INC | $82.75 | 2021-2022 | |
| Abbvie INC. | $39.10 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.20 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.58 | 2019 | |
| Pfizer INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chih-Hong Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.